Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Receivables (2024 - 2025)

Updated

Raphael Pharmaceutical (RAPH) recorded Receivables of $2,000 in Q4 2025, unchanged from $2,000 a year earlier.

Analysis

Raphael Pharmaceutical (RAPH) Receivables (2024 - 2025) Analysis & Trends

  • Across earlier years, Receivables came in at $2,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Raphael Pharmaceutical 28.25 Mn 28.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2,000.00
Dec 31, 2024 2,000.00
API Access

Raphael Pharmaceutical Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=RAPH&period=max&api_key=YOUR_API_KEY